This material contains content that is copyright of SNOMED International. Implementers of these specifications must have the appropriate SNOMED CT Affiliate license - for more information contact https://www.snomed.org/get-snomed
or info@snomed.org
.
HL7 Europe Base and Core FHIR IG, published by HL7 Europe. This guide is not an authorized publication; it is the continuous build for version 0.2.0-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/base/ and changes regularly. See the Directory of published versions ( src
)
There are examples where a medication request may include the option of an oral dose or an Intravenous or Intramuscular dose. For example, "Ondansetron 8mg orally or IV twice a day as needed for nausea" or "Compazine® (prochlorperazine) 5-10mg PO or 25mg PR bid prn nausea or vomiting". In these cases, two medication requests would be created that could be grouped together. The decision on which dose and route of administration to use is based on the patient's condition at the time the dose is needed. ( src
)
This Implementation Guide (IG) brings together base and core HL7® FHIR® artifacts designed specifically for the European context. ( src
)
Code that identifies the allergy or intolerance Binding:
Allergy Intolerance - IPS (preferred): Type of the substance/product, allergy or intolerance condition or a code for absent/unknown allergy.
Identification of the condition, problem or diagnosis Binding:
eHDSI Illness and Disorder (preferred): Valueset to describe the actual problem experienced by the patient
HL7 Europe Base and Core FHIR IG, published by HL7 Europe. This guide is not an authorized publication; it is the continuous build for version 0.2.0-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/base/
and changes regularly. See the Directory of published versions
The codes SHOULD be taken from For example codes, see
Allergy Intolerance - IPS http://hl7.org/fhir/ValueSet/allergyintolerance-code|4.0.1
( preferred
to http://hl7.org/fhir/uv/ips/ValueSet/allergy-intolerance-uv-ips
)
Code that identifies the allergy or intolerance Binding:
Allergy Intolerance - IPS (preferred): Type of the substance/product, allergy or intolerance condition or a code for absent/unknown allergy.
Code that identifies the allergy or intolerance Binding:
Allergy Intolerance - IPS (preferred): Type of the substance/product, allergy or intolerance condition or a code for absent/unknown allergy.
The codes SHOULD be taken from For example codes, see
eHDSI Illness and Disorder http://hl7.org/fhir/ValueSet/condition-code|4.0.1
( preferred
to http://terminology.ehdsi.eu/ValueSet/eHDSIIllnessandDisorder
)
Identification of the condition, problem or diagnosis Binding:
eHDSI Illness and Disorder (preferred): Valueset to describe the actual problem experienced by the patient
For example codes, see
eHDSI Dose Form http://hl7.org/fhir/ValueSet/medication-form-codes|4.0.1
( example
to http://terminology.ehdsi.eu/ValueSet/eHDSIDoseForm
)
This page describes the element-by-element mapping from the
EHDSHumanName
logical model to the HL7 FHIR
HumanName
datatype, as used in this Implementation Guide.
This page describes the element-by-element mapping from the EHDSLocation
logical model to the LocationEuCore
FHIR profile, which represents physical service delivery sites and care locations.
This page describes the element-by-element mapping from the EHDSHumanName
logical model to the HL7 FHIR HumanName
datatype, as used in this Implementation Guide.
(
preferred
)
:
Type of the substance/product, allergy or intolerance condition or a code for absent/unknown allergy.
